Ozempic Launches in India: Novo Nordisk's Diabetes and Weight Loss Drug Enters World's Second-Largest Diabetes Market

Dec 12, 2025 05:46 pm CST

Novo Nordisk has introduced Ozempic to the Indian market, pricing the diabetes medication at Rs 8,800-11,175 monthly across three dosages. The strategic launch targets India's significant diabetic population before generic competitors arrive in 2026. Beyond blood sugar control, Ozempic offers weight loss benefits and reduced cardiovascular risks, but remains prescription-restricted for medical use only.